04 September 2019
Visiongain has launched a new pharma report Blood Screening Market Forecast 2019-2029: By Technology (NAT, ELISA, CLIA, NGS, Western Blotting) & By Product (Reagents, Instruments) Segments.
The growth of the global blood screening market is attributed to the increase in screening of donor and continuous technological advancement by the market players. Moreover, there is ever increasing demand for blood screening tests due to increasing donation, rising awareness about transfusion-transmitted diseases, and technological developments in the industry. Also, governments across the countries are in process to mandates testing all donated blood for several viruses.
Blood donation requires the blood to be free from disease causing agents namely HIV-1, HIV-2, hepatitis virus, West Nile Virus (WNV), Human T-Lymphotropic Virus (HTLV) T. Cruzi, and T. pallidum (syphilis). This is done to decrease the chances of transfusion-transmitted contaminations (TTIs).
With continuous technological advancement in this segment, especially the U.S. FDA approved next-generation sequencing (NGS) technology in 2013 has made the blood screening cheaper and faster than previous DNA analysis methods has done well for the industry. The worldwide blood screening market is witnessing technological advancements with respect to devices and utilities involved in blood donation centres and doctor’s facilities for the screening of different TTIs.
Leading companies featured in the report include Grifols, F. Hoffmann-La Roche, Abbott Laboratories, Biomérieux, Bio-Rad Laboratories, Inc., Siemens Healthineers (A Subsidiary Of Siemens AG), Ortho Clinical Diagnostics, Inc., Thermo Fisher Scientific, Inc., Beckman Coulter (A Subsidiary Of Danaher Corporation), Becton, Dickinson And Company.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The rising prevalence of oncological disorders, lung infections, rising demand for customised drugs coupled with new orphan diseases discoveries, are few of the major reasons responsible for development of pharmaceutical spray drying market.
25 October 2021
Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.
11 October 2021
High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.
07 October 2021
Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.